Rachel Clapham Profile
Rachel Clapham

@racheleclapham

Followers
95
Following
173
Statuses
39

NIHR Doctoral clinical and academic fellow. Pharmacist. King’s Thrombosis Centre, London.

Joined April 2012
Don't wanna be here? Send us removal request.
@racheleclapham
Rachel Clapham
4 months
0
0
1
@racheleclapham
Rachel Clapham
6 months
Very excited to share our work on the use of edoxaban at extremes of bodyweight and renal function completed as part of my NIHR PCAF! @VictoriaSpeed3 @AryaRoopen @LaraNRoberts1 @KCHPharmacy
0
9
24
@racheleclapham
Rachel Clapham
7 months
@ReenaM2703 @LSEHealthPolicy Congratulations, what an achievement!!
1
0
1
@racheleclapham
Rachel Clapham
8 months
@NATFthrombosis @AnticoagPharmD @MAPharmacists Congratulations, what an amazing achievement!
0
0
1
@racheleclapham
Rachel Clapham
9 months
RT @AryaRoopen: Congrats ⁦@racheleclapham⁩ on NIHR DCAF award towards your PhD studies! Welcome back 2 King’s Thrombosis Centre team! ⁦@Kin
0
3
0
@racheleclapham
Rachel Clapham
9 months
@ChrisRemmington @cathymac40 @ProfLouiseR @Luigi_ICM @frankjonhank @NIHRcommunity Congratulations Chris! I was successful too, glad we can do it together!
0
0
5
@racheleclapham
Rachel Clapham
9 months
RT @AryaRoopen: Our Invited Commentary: Venous Thromboembolism Risk Assessment Models for Acutely Ill Medical Patients—Back to the Drawing…
0
9
0
@racheleclapham
Rachel Clapham
9 months
@ChrisRemmington @GSTT_ICU @BJAJournals @GSTT_Pharmacy Well done, Chris! Really interesting read!
0
0
1
@racheleclapham
Rachel Clapham
10 months
RT @bhwords: Advances & current research in primary thromboprophylaxis to prevent hospital-associated VTE - with ⁦@LaraNRoberts1⁩ ⁦@AryaRoo
0
10
0
@racheleclapham
Rachel Clapham
11 months
RT @VictoriaSpeed3: DOACs at extremes of bodyweight. Ever wondered how many patients over <50kg & >120kg are prescribed DOACs IRL🧮🤔? The fa…
0
8
0
@racheleclapham
Rachel Clapham
1 year
RT @AryaRoopen: Balancing the risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: oh, for a crystal ball!…
0
18
0
@racheleclapham
Rachel Clapham
1 year
RT @AnticoagPharmD: 🌟Proud to contribute to this PATIENT FRIENDLY guide to Periprocedural Management of Antithrombotics @NATFthrombosis Th…
0
9
0
@racheleclapham
Rachel Clapham
1 year
RT @VictoriaSpeed3: Excited🥳 to share our #rpthillustratedreview on DOACs from a clinical and pharmacy PK perspective🩺💊Fond brainstorming m…
0
19
0
@racheleclapham
Rachel Clapham
1 year
RT @AryaRoopen: ART meets SCIENCE! Final version #RPTHIllustratedReview on use #DOACs at extremes is online. V. much a tag-team effort by o…
0
15
0
@racheleclapham
Rachel Clapham
1 year
RT @ThrombUpdate: New article alert in @ThrombUpdate VTE prevention in medical inpatients - Current approach and controversies https://t.c…
0
6
0
@racheleclapham
Rachel Clapham
1 year
0
0
1
@racheleclapham
Rachel Clapham
1 year
RT @RPTHjournal: 🩸💊Are you curious how to manage #DOACS in patients at extremes of body weight, kidney and liver function? Check out this…
0
53
0
@racheleclapham
Rachel Clapham
1 year
RT @RPTHjournal: A6: #Thrombosis can affect people of all ages and backgrounds. Initiating formal national #VTE prevention programs, as de…
0
5
0